CRADD Antikörper (AA 1-199)
CRADD
Reaktivität: Human
WB, IP
Wirt: Kaninchen
Polyclonal
unconjugated
-
-
Target
Alle CRADD Antikörper anzeigen
-
CRADD
(CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
-
Bindungsspezifität
-
AA 1-199
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser CRADD Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunoprecipitation (IP)
-
Spezifität
-
Recognizes RAIDD Species Reactivity: Human. Other species not tested.
-
Immunogen
-
Recombinant human RAIDD (aa 1-199) fused at the N-terminus to a tag.
-
Top Product
-
Discover our top product CRADD Primärantikörper
-
-
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
50 µg of affinity purified antibody at 1 mg/mL with 0.02% sodium azide.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
4 °C
-
-
Target
-
CRADD
(CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
-
Andere Bezeichnung
-
RAIDD (CRADD Produkte)
-
Synonyme
-
cradd antikoerper, MGC89035 antikoerper, zgc:101717 antikoerper, CRADD antikoerper, DKFZp468A2219 antikoerper, LOC100226369 antikoerper, raidd antikoerper, MGC78788 antikoerper, MRT34 antikoerper, RAIDD antikoerper, CASP2 and RIPK1 domain containing adaptor with death domain antikoerper, CASP2 and RIPK1 domain containing adaptor with death, gene 1 antikoerper, CASP2 and RIPK1 domain containing adaptor with death, gene 2 S homeolog antikoerper, CRADD antikoerper, cradd.1 antikoerper, cradd antikoerper, cradd.2.S antikoerper, Cradd antikoerper
-
Pathways
-
Apoptose, Caspase Kaskade in der Apoptose, Positive Regulation of Endopeptidase Activity
-